0.58 USD
↗ 0.05 (8.41%)LIVE (AS OF 02:10 PM EST)
Citius Oncology, Inc. Common Stock (CTOR) is currently trading at $0.58. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. CTOR is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 16, 2026.